Advertisement

Related Videos

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Welcome and Introduction to Vi3C

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




May
02
Today In Oncology
Glecirasib Shows Efficacy and Safety in KRAS G12C–Mutated NSCLC
Metastatic Castration-Resistant Prostate Cancer Addition of LuPSMA to Enzalutamide
Breast Implant–Related Cancers: Should Our Patients Be Concerned?
Pediatric AML Comparison of Induction Regimens
Older Patients With Newly Diagnosed Hodgkin Lymphoma Preexisting Heart Failure and Survival Outcomes
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside